Jordan Bateman is an associate in the San Diego office of Wilson Sonsini Goodrich & Rosati, where he is a member of the firm’s patents and innovations practice.
During law school, Jordan concentrated on intellectual property and participated in the Entrepreneurial Law Clinic. There, he advised start-up clients on trademark, trade secret, copyright, and patent matters, and developed comprehensive IP strategies tailored to early-stage technologies.
Prior to law school, Jordan received a Ph.D. in pharmacology and therapeutics from the University of Florida. His doctoral research, supported by a competitive NIH predoctoral fellowship, focused on understanding the neural mechanisms of opioid-induced respiratory failure.
Jordan previously served as a law clerk at an IP-focused firm, where he gained experience in pharmaceutical and biotechnology patent prosecution.
Jordan Bateman is an associate in the San Diego office of Wilson Sonsini Goodrich & Rosati, where he is a member of the firm’s patents and innovations practice.
During law school, Jordan concentrated on intellectual property and participated in the Entrepreneurial Law Clinic. There, he advised start-up clients on trademark, trade secret, copyright, and patent matters, and developed comprehensive IP strategies tailored to early-stage technologies.
Prior to law school, Jordan received a Ph.D. in pharmacology and therapeutics from the University of Florida. His doctoral research, supported by a competitive NIH predoctoral fellowship, focused on understanding the neural mechanisms of opioid-induced respiratory failure.
Jordan previously served as a law clerk at an IP-focused firm, where he gained experience in pharmaceutical and biotechnology patent prosecution.
- J.D., University of Washington School of Law, 2025
Concentration in Intellectual Property
- University of Washington Foster School of Business Technology Entrepreneurship Certificate Program, 2025
- Ph.D., Pharmacology and Therapeutics, University of Florida, 2022
- B.S., Physiology and Developmental Biology, Brigham Young University, 2017
- Recipient, The National Institutes of Health’s Ruth L. Kirschstein National Research Service Award for Individual Predoctoral Fellows (F31)
- State Bar of California
- U.S. Patent and Trademark Office
- J.D., University of Washington School of Law, 2025
Concentration in Intellectual Property
- University of Washington Foster School of Business Technology Entrepreneurship Certificate Program, 2025
- Ph.D., Pharmacology and Therapeutics, University of Florida, 2022
- B.S., Physiology and Developmental Biology, Brigham Young University, 2017
- Recipient, The National Institutes of Health’s Ruth L. Kirschstein National Research Service Award for Individual Predoctoral Fellows (F31)
- State Bar of California
- U.S. Patent and Trademark Office
Select Publications
- Co-author with S. Maletz, B. Reid, D. Baekey, J. Whitaker-Fornek, J. Bissonnette, and E. Levitt, “Effect of positive allosteric modulation and orthosteric agonism of dopamine D2 receptors on respiration in mouse models of Rett Syndrome,” 328 Respiratory Physiology & Neurobiology 104314, 2024
- Co-author with E. Levitt, “Opioid suppression of an excitatory pontomedullary respiratory circuit by convergent mechanisms,” 12 eLife e81119, 2023
- Co-author with S. Saunders and E. Levitt, “Understanding and countering opioid-induced respiratory depression,” 180(7) British Journal of Pharmacology 813-828, 2023
- Co-author with E. Levitt, “Evaluation of G protein bias and β-arrestin 2 signaling in opioid-induced respiratory depression,” 321(4) American Journal of Physiology-Cell Physiology C681-C683, 2021
- Co-author with A. Varga, S. Maletz, B. Reid, and E. Levitt, “Neurochemistry of the Kölliker-Fuse nucleus from a respiratory perspective,” 156(1) Journal of Neurochemistry 16-37, 2021
- Co-author with A. Kliewer, F. Schmiedel, S. Sianati, A. Bailey, E. Levitt, J. Williams, M. Christie, and S. Schulz, “Enhanced opioid analgesia and loss of tolerance, but exacerbated side effects in mice expressing G-protein biased, phosphorylation-deficient µ-receptors,” 10(1) Nature Communications 367, 2019
- Co-author with M. Hashemi, J. Rovig, B. Holden, T. Modelzelewski, I. Gueorguieva, M. von Dyck, R. Bracken, C. Genberg, S. Deng, and P. Savage, “Preclinical testing of broad-spectrum antimicrobial endotracheal tube coated with an innate immune synthetic mimic,” 73(1) Journal of Antimicrobial Chemotherapy 143-150, 2018
Select Publications
- Co-author with S. Maletz, B. Reid, D. Baekey, J. Whitaker-Fornek, J. Bissonnette, and E. Levitt, “Effect of positive allosteric modulation and orthosteric agonism of dopamine D2 receptors on respiration in mouse models of Rett Syndrome,” 328 Respiratory Physiology & Neurobiology 104314, 2024
- Co-author with E. Levitt, “Opioid suppression of an excitatory pontomedullary respiratory circuit by convergent mechanisms,” 12 eLife e81119, 2023
- Co-author with S. Saunders and E. Levitt, “Understanding and countering opioid-induced respiratory depression,” 180(7) British Journal of Pharmacology 813-828, 2023
- Co-author with E. Levitt, “Evaluation of G protein bias and β-arrestin 2 signaling in opioid-induced respiratory depression,” 321(4) American Journal of Physiology-Cell Physiology C681-C683, 2021
- Co-author with A. Varga, S. Maletz, B. Reid, and E. Levitt, “Neurochemistry of the Kölliker-Fuse nucleus from a respiratory perspective,” 156(1) Journal of Neurochemistry 16-37, 2021
- Co-author with A. Kliewer, F. Schmiedel, S. Sianati, A. Bailey, E. Levitt, J. Williams, M. Christie, and S. Schulz, “Enhanced opioid analgesia and loss of tolerance, but exacerbated side effects in mice expressing G-protein biased, phosphorylation-deficient µ-receptors,” 10(1) Nature Communications 367, 2019
- Co-author with M. Hashemi, J. Rovig, B. Holden, T. Modelzelewski, I. Gueorguieva, M. von Dyck, R. Bracken, C. Genberg, S. Deng, and P. Savage, “Preclinical testing of broad-spectrum antimicrobial endotracheal tube coated with an innate immune synthetic mimic,” 73(1) Journal of Antimicrobial Chemotherapy 143-150, 2018
- Privacy Policy
- Terms of Use
- Accessibility